New Data Shows Unparalleled Overall Survival Improvement with ChemoFx!
Data recently published by the journal Gynecologic Oncology shows ChemoFx® results were associated with a 14 month increase in mean overall survival and a 50% longer progression-free survival -
CLICK HERE to learn more about this exciting data!

Our commitment
More
Precision's Comprehensive Tumor Profiles offer a portfolio of products developed to help guide physicians and patients with difficult clinical decisions throughout the Cancer Care Continuum.

Precision’s ongoing array of multiple products and technologies provide unique clinical value through a Comprehensive Tumor Profile, which includes: ChemoFx®, BioSpeciFx® and GeneFx Colon®. This approach to precision medicine combines genomic expression and molecular information specific and clinically relevant to a patient’s cancer, answering a broad range of clinical questions that physicians encounter every day while managing their patient’s care.

GeneFx Colon

BioSpeciFx

GeneFx Colon

More